Nasdaq Portfolio Solutions ChannelLooking to Play Intellia’s Ground-Breaking Gene Therapy?By Karrie GordonJuly 6, 2021
Nasdaq Portfolio Solutions ChannelGoldman Sachs Likes These Health Tech StocksBy Todd ShriberJune 9, 2021
Multi-Factor ChannelInvesting for Tomorrow, Today: Exploring the Future of Health CareBy Max ChenApril 28, 2021
Nasdaq Portfolio Solutions ChannelHealth Tech x Remote Work: Principal’s BTEC ETFBy Tom LydonApril 6, 2021
Nasdaq Portfolio Solutions ChannelAI Can Drive the Next Generation of Healthcare InnovationBy Tom LydonMarch 24, 2021
Nasdaq Portfolio Solutions ChannelBank on BTEC in the Ever-Elusive Search for Healthcare InnovationBy Tom LydonFebruary 12, 2021
FeaturedModerna Helps Biotech ETFs Mitigate Massive Losses as Stocks TumbleBy Ian YoungJanuary 4, 2021
Multi-Factor ChannelThe BTEC ETF: Access to Consistent Healthcare InnovationBy Tom LydonDecember 8, 2020
Alternatives ChannelPrincipal’s BTEC ETF Luring Investors Seeking Telemedicine ExposureBy Tom LydonNovember 18, 2020
Multi-Factor ChannelETF Opportunities Abound in an Increasingly Monolithic Healthcare IndustryBy Tom LydonNovember 13, 2020
Multi-Factor ChannelThe Intensifying Vaccine Race Spells Success for BTECBy Tom LydonOctober 29, 2020
Multi-Factor ChannelIs Principal’s BTEC the Healthcare ETF to Hold Come Election Day?By Tom LydonOctober 27, 2020
